The safety of the dissection of lymph node stations 5 and 6 in pylorus-preserving gastrectomy.
BACKGROUND
This study was intended to examine the safety of possibly incomplete dissection of lymph node stations (LNS) 5 and 6 in pylorus-preserving gastrectomy (PPG) for gastric cancer.


METHODS
We reviewed the medical information from 1802 gastric cancer patients who underwent curative gastrectomy and whose lymph nodes were topographically classified according to LNS between March 2003 and December 2008. We divided the patients who underwent subtotal gastrectomy into 2 groups according to the distance between the distal resection margin (DRM) and primary tumor: those with a distance of < 6 cm (the < 6 DRM group) and those with a distance of >or= 6 cm (the >or= 6 DRM group). We analyzed the lymph node metastasis rate to LNS 5 and 6 according to T stage and the location. The number of retrieved lymph nodes according to LNS was compared between subtotal gastrectomy (STG) and PPG.


RESULTS
The metastasis rate to LNS 5 was very rare in >or= 6 DRM group: T1a, 0% (0 of 105); T1b, 0.9% (1 of 113); and T2a, 0% (0 of 56), although the number of retrieved LNS 5 was significantly lower in PPG than in STG. The metastasis rate to LNS 6 in the >or= 6 DRM group was significantly lower than in the < 6 DRM group, but higher than that of LNS 5: T1a, 0% (0 of 107); T1b, 1.8% (2 of 114); and T2a, 3.6% (2 of 56). The number of retrieved LNS 6 was not significantly different between STG and PPG.


CONCLUSIONS
PPG seems to be safe for early gastric cancer located >or= 5 cm from the pylorus in terms of LNS 5 and 6.
Kong
Seong-Ho
SH
Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.
Kim
Jong Won
JW
Lee
Hyuk-Joon
HJ
Kim
Woo Ho
WH
Lee
Kuhn Uk
KU
Yang
Han-Kwang
HK
D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D005743:Gastrectomy; D006801:Humans; D010535:Laparoscopy; D008197:Lymph Node Excision / Q000592:standards*; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D011446:Prospective Studies; D011708:Pylorus / Q000601:surgery*; D013274:Stomach Neoplasms / Q000473:pathology / Q000601:surgery*; D015996:Survival Rate; D016896:Treatment Outcome